The stock market will be on edge this week as investors continue focusing on the ongoing Iran war. This focus comes at a time when the Dow Jones, Nasdaq 100, and S&P 500 indices have plunged from their all-time highs. This article explores some of the top US stocks to watch this week, including companies… Continue reading Top stocks to watch this week: Tilray Brands, Nike, FactSet
Stock Research
HDFC Bank stock falls, but JPMorgan, Jefferies see valuation upside
Shares of HDFC Bank have come under sustained pressure this year, declining more than 26% and lagging both peers and the broader market, even as brokerages turn increasingly positive on the stock following the sharp correction. The recent underperformance has prompted global brokerage JPMorgan to upgrade the stock to “Overweight” from “Neutral”, citing a more… Continue reading HDFC Bank stock falls, but JPMorgan, Jefferies see valuation upside
FTSE 100 rises on miners, energy as Middle East tensions persist
London’s FTSE 100 rose on Monday, helped by gains in heavyweight miners and energy producers that offset weakness elsewhere. Firmer commodity prices supported the move, even as investors stayed cautious with the Middle East conflict entering its fifth week, Reuters reported. By 09:21 GMT, the blue-chip index was up 0.6%, while the FTSE 250 fell… Continue reading FTSE 100 rises on miners, energy as Middle East tensions persist
IQM lands over $57M from BlackRock ahead of $1.8B dual listing push
IQM Quantum Computers has secured €50 million ($57.64 million) in venture financing from funds and accounts managed by BlackRock, positioning the Finnish firm to accelerate its global expansion ahead of a planned dual listing in the US and Helsinki. Earlier this year, IQM outlined plans to go public via a merger with a special purpose… Continue reading IQM lands over $57M from BlackRock ahead of $1.8B dual listing push
BofA names 2 fintech stocks for outsized long-term gains
As market volatility whipsaws major indices and leaves investors wary of overstretched valuations in the more notable names, Bank of America is urging a pivot toward high-conviction plays flying under the radar. While tech remains the primary engine of global growth, BofA’s latest research report suggests the best risk-reward may now lie in specialized fintech… Continue reading BofA names 2 fintech stocks for outsized long-term gains
Morgan Stanley cuts global equities, boosts cash and US Treasuries
Morgan Stanley has adopted a more defensive stance, downgrading global equities and upgrading cash and US government bonds amid rising oil supply risks from the Middle East conflict, Reuters reported. The bank lowered global equities to equal weight from overweight and lifted cash and Treasuries to overweight from equal weight, citing “asymmetric outcomes” for risk assets in an environment of surging crude… Continue reading Morgan Stanley cuts global equities, boosts cash and US Treasuries
Mistral secures $830M for Nvidia-powered Paris AI hub expansion
French AI startup Mistral AI is accelerating its infrastructure ambitions after securing $830 million in debt financing for a major data centre near Paris. The move marks another important step in Europe’s race to build sovereign AI capacity. Announced on Monday, the financing will support a facility powered by 13,800 Nvidia GB300 GPUs. The site… Continue reading Mistral secures $830M for Nvidia-powered Paris AI hub expansion
STOXX 600 flat, FTSE 100 gains as oil surge, geopolitics weigh
European markets opened little changed on Monday, reflecting the cautious tone seen across global equities overnight. The pan-European STOXX 600 was flat at 574.98 points in early trade, while the UK’s FTSE 100 edged 0.2% higher. Across the region, sentiment remained subdued, with investors continuing to weigh the impact of rising oil prices and geopolitical… Continue reading STOXX 600 flat, FTSE 100 gains as oil surge, geopolitics weigh
Eli Lilly inks $2.75B AI deal with Insilico, bets on China biotech
Global pharmaceutical major Eli Lilly has signed a drug discovery agreement with Insilico Medicine that could be worth up to $2.75 billion. The deal underscores the growing role of artificial intelligence and China’s biotech ecosystem in shaping the future of drug development. The deal, announced on Sunday, will see Insilico receive an upfront payment of… Continue reading Eli Lilly inks $2.75B AI deal with Insilico, bets on China biotech
